AVORO CAPITAL ADVISORS LLC 13D and 13G filings for CymaBay Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 09:09 am Purchase |
2023-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
AVORO CAPITAL ADVISORS LLC | 16,337,739 9.990% |
3,537,739 (+27.64%) |
Filing |
| 2022-02-11 10:03 am Purchase |
2021-12-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
AVORO CAPITAL ADVISORS LLC | 12,800,000 14.700% |
2,500,000 (+24.27%) |
Filing |
| 2020-09-01 12:25 pm Purchase |
2020-08-31 | 13G | CymaBay Therapeutics, Inc. CBAY |
AVORO CAPITAL ADVISORS LLC | 10,300,000 14.950% |
4,800,000 (+87.27%) |
Filing |